Abstract
Cognitive dysfunction is a common occurrence among patients with small-cell lung cancer, with prevalence rates ranging anywhere from 15% to 90%. Although prophylactic cranial irradiation has been described as one culprit to explain these cognitive deficits, other causes also have been implicated. This review provides a summary of the factors that may contribute to cognitive decline in this group of patients and comments upon how cognitive dysfunction or the risk for it might influence patient management.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 127-132 |
| Number of pages | 6 |
| Journal | Journal of Supportive Oncology |
| Volume | 2 |
| Issue number | 2 |
| State | Published - Mar 1 2004 |
ASJC Scopus subject areas
- Oncology
- Pharmacology (medical)